6-K
Indivior Pharmaceuticals, Inc. (INDV)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
________________________
Washington, D.C. 20549
_____________________
FORM 6-K
_____________________
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of February 2025
Commission File Number: 001-37835
________________________________________
Indivior PLC
________________________________________
10710 Midlothian Turnpike, Suite 125
North Chesterfield, Virginia 23235
(Address of principal executive office)
_______________________________
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F
Form 20-F ☒ Form 40-F ☐
EXHIBIT INDEX
| Exhibit No. | Description<br>of Exhibit |
|---|---|
| 99.1 | Announcement sent<br>to the London Stock Exchange on February 28, 2025, titled<br>“Director/PDMR Shareholding”. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Indivior PLC | |
|---|---|
| Date: February 28, 2025 | /s/<br>Kathryn Hudson |
| Name:<br>Kathryn Hudson | |
| Title:<br>Company Secretary |
a8984y-announcement
Exhibit 99.1
INDIVIOR PLC (THE 'COMPANY')
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM
The Company announces that it received notification on February 27, 2025 that Joseph Ciaffoni, a Non-Executive Director of the Company, acquired a total of 56,000 Ordinary Shares of US$0.50 each in the Company ('Shares') at an average price of $8.9557 per Share on February 27, 2025.
Following this transaction, Joseph Ciaffoni has an interest in 56,000 Shares in the Company.
| 1 | Details of the person discharging managerial responsibilities /<br>person closely associated | ||
|---|---|---|---|
| a) | Name | Joseph<br>Ciaffoni | |
| 2 | Reason for the notification | ||
| a) | Position/status | Non-Executive<br>Director / PDMR | |
| b) | Initial notification /Amendment | Initial<br>notification | |
| 3 | Details of the issuer, emission allowance market participant,<br>auction platform, auctioneer or auction monitor | ||
| a) | Name | Indivior<br>PLC | |
| b) | LEI | 213800V3NCQTY7IED471 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each<br>type of instrument; (ii) each type of transaction; (iii) each date;<br>and (iv) each place where transactions have been<br>conducted | ||
| a) | Description of the financial instrument, type of<br>instrument<br><br><br><br><br><br>Identification<br>code | Ordinary Shares of US0.50<br><br><br> <br><br>GB00BN4HT335 | |
| b) | Nature of the transaction | Purchase<br>of Shares | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| $8.9557 | 56,000 | ||
| d) | Aggregated information<br><br><br><br><br><br>- Aggregated volume<br><br><br><br><br><br>- Price | N/A | |
| e) | Date of the transaction | February<br>27, 2025 | |
| f) | Place of the transaction | Nasdaq<br>Global Select Market |
All values are in US Dollars.